MKD/USD Price & Performance (MKDUSD)

Everest Medicines is set to release its full-year financial results for 2024 on March 26, 2025. The announcement will highlight the company’s progress in developing and marketing innovative therapeutics. Investors are keen on updates regarding its pipeline advancements and financial performance as the biopharmaceutical sector remains highly competitive.12

Cornerstone Technologies announced its revenue nearly doubled to HK$153.1 million in 2024, driven by growth in its EV charging services. The company also expanded its public charging network significantly and entered the Thai market, highlighting the growing demand for EV infrastructure globally.3

Nio’s stock saw a sharp decline following competitor BYD’s new charging technology announcement. Despite this, analysts remain optimistic about Nio’s growth potential, citing its expanding product portfolio, battery-swapping technology, and international market penetration as key drivers for future performance.4